Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196557 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject
A Phase 1 study of Immunoscience, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT03196557 is a Phase 1 study of Immunoscience that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 24 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03196557, a Phase 1 study of Immunoscience, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Prenisolone
Study Locations (2)
Texas
- Ppd Development - Austin
- Local Institution - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-03-31 |
| Est. Completion | 2008-05-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03196557
The ClinicalTrials.gov registry entry for NCT03196557 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immunoscience appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03196557 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03196557 about?
NCT03196557 is a clinical study titled "A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject". The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects
What is the current status of trial NCT03196557?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-03-31. Estimated completion is 2008-05-05.
What conditions does trial NCT03196557 study?
This clinical trial studies the following conditions: Immunoscience.
What interventions are being tested in trial NCT03196557?
The interventions under investigation include: Placebo (DRUG), Prenisolone (DRUG).
Who is sponsoring clinical trial NCT03196557?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03196557 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.